Levels of MAP1S in HK-2 cells were the highest, while levels of MAP1S were dramatically reduced in all other cell lines developed from human primary ccRCC (786-0, RCC4, A498 and Caki-1) (Figure 2A). The gene discussed is MAP1S; the disease is nonpapillary renal cell carcinoma.